Business Description

Description
Skinvisible Inc is a pharmaceutical research and development company that has developed and patented a polymer delivery system, Invisicare and formulated over forty topical skin products, which it out-licenses globally. Invisicare is a patented polymer delivery system that enhances the delivery of active ingredients for topically applied skin care products. Its patented technology has a formula and process for combining active ingredients with a delivery system that extends the duration of time the product remains on the skin and active. The Company is also exploring new opportunities in large medical markets outside of the dermatology market such as obesity and other potential markets where a topical or transdermal solution would be a viable alternative.

Financial Strength

Name Current Vs Industry Vs History
Equity-to-Asset -55.36
Debt-to-Equity -0.68
Debt-to-EBITDA -12.93
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -373.71
Distress
Grey
Safe
Beneish M-Score -54.41
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 41.71
9-Day RSI 43.09
14-Day RSI 44.45
6-1 Month Momentum % 14.75
12-1 Month Momentum % -29.29

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.01
Quick Ratio 0.01
Days Sales Outstanding 91.25

Dividend & Buy Back

Name Current Vs Industry Vs History
Shareholder Yield % -944.91

Profitability Rank

Name Current Vs Industry Vs History
Operating Margin % -2455
Net Margin % -11915
FCF Margin % -440
ROA % -1195.09
ROIC % -78.64
Years of Profitability over Past 10-Year 1

GF Value Rank

Name Current Vs Industry Vs History
PS Ratio 15.53
EV-to-EBIT -12.97
EV-to-EBITDA -13.52
EV-to-Revenue 321.7
EV-to-FCF -73.11
Price-to-Median-PS-Value 1.55
Earnings Yield (Greenblatt) % -7.71
FCF Yield % -31.21

Financials

SKVI's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with OTCPK:SKVI

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Skinvisible Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0.02
EPS (TTM) ($) -0.51
Beta 0.54
Volatility % 68.78
14-Day RSI 44.45
14-Day ATR ($) 0.006684
20-Day SMA ($) 0.07571
12-1 Month Momentum % -29.29
52-Week Range ($) 0.055 - 0.1399
Shares Outstanding (Mil) 4.54

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Skinvisible Inc Filings

Filing Date Document Date Form
No Filing Data

Skinvisible Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Skinvisible Inc Frequently Asked Questions

What is Skinvisible Inc(SKVI)'s stock price today?
The current price of SKVI is $0.06. The 52 week high of SKVI is $0.14 and 52 week low is $0.06.
When is next earnings date of Skinvisible Inc(SKVI)?
The next earnings date of Skinvisible Inc(SKVI) is .
Does Skinvisible Inc(SKVI) pay dividends? If so, how much?
Skinvisible Inc(SKVI) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1